Growth Metrics

Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2021 - 2025)

Biolife Solutions (BLFS) has disclosed Non-Current Deferred Tax Liability for 5 consecutive years, with $189000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 89.0% to $189000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $189000.0, a 89.0% increase, with the full-year FY2024 number at $124000.0, down 34.04% from a year prior.
  • Non-Current Deferred Tax Liability was $189000.0 for Q3 2025 at Biolife Solutions, up from $175000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11.2 million in Q4 2022 to a low of $100000.0 in Q3 2024.
  • A 5-year average of $2.4 million and a median of $263000.0 in 2023 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: soared 104.7% in 2022, then plummeted 98.33% in 2023.
  • Biolife Solutions' Non-Current Deferred Tax Liability stood at $5.5 million in 2021, then skyrocketed by 104.7% to $11.2 million in 2022, then tumbled by 98.33% to $188000.0 in 2023, then plummeted by 34.04% to $124000.0 in 2024, then skyrocketed by 52.42% to $189000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Non-Current Deferred Tax Liability are $189000.0 (Q3 2025), $175000.0 (Q2 2025), and $130000.0 (Q1 2025).